This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1990 Mar;39(3):438-90.

doi: 10.2165/00003495-199039030-00008.

Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer

J M Henwood¹, R N Brogden

Affiliations

PMID: 2184009
DOI: 10.2165/00003495-199039030-00008

Review

Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer

J M Henwood et al. Drugs. 1990 Mar.

. 1990 Mar;39(3):438-90.

doi: 10.2165/00003495-199039030-00008.

Authors

J M Henwood¹, R N Brogden

Affiliation

¹ ADIS Drug Information Services, Manchester, England.

PMID: 2184009
DOI: 10.2165/00003495-199039030-00008

No abstract available

PubMed Disclaimer

Similar articles

Developmental pharmacokinetics of etoposide in 67 children: lack of dexamethasone effect.
Urien S, Doz F, Giraud C, Rey E, Gentet JC, Chastagner P, Vassal G, Corradini N, Auvrignon A, Leblond P, Rubie H, Treluyer JM. Urien S, et al. Cancer Chemother Pharmacol. 2011 Mar;67(3):597-603. doi: 10.1007/s00280-010-1357-2. Epub 2010 May 20. Cancer Chemother Pharmacol. 2011. PMID: 20490798 Clinical Trial.
Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062).
Miller AA, Rosner GL, Ratain MJ, Hollis DR, Green MR, Schilsky RL. Miller AA, et al. Clin Cancer Res. 1997 May;3(5):719-25. Clin Cancer Res. 1997. PMID: 9815741 Clinical Trial.
Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study.
You B, Tranchand B, Girard P, Falandry C, Ribba B, Chabaud S, Souquet PJ, Court-Fortune I, Trillet-Lenoir V, Fournel C, Tod M, Freyer G. You B, et al. Lung Cancer. 2008 Nov;62(2):261-72. doi: 10.1016/j.lungcan.2008.03.008. Epub 2008 Apr 28. Lung Cancer. 2008. PMID: 18442869 Clinical Trial.
Intraperitoneal chemotherapy: application to upper gastrointestinal neoplasms.
Howell SB, Zimm S. Howell SB, et al. Acta Chir Scand Suppl. 1988;541:16-21. Acta Chir Scand Suppl. 1988. PMID: 3291515 Review. No abstract available.
Pharmacokinetic optimisation of treatment with oral etoposide.
Toffoli G, Corona G, Basso B, Boiocchi M. Toffoli G, et al. Clin Pharmacokinet. 2004;43(7):441-66. doi: 10.2165/00003088-200443070-00002. Clin Pharmacokinet. 2004. PMID: 15139794 Review.

See all similar articles

Cited by

Optimal drug therapy in the treatment of testicular cancer.
Priest ER, Vogelzang NJ. Priest ER, et al. Drugs. 1991 Jul;42(1):52-64. doi: 10.2165/00003495-199142010-00004. Drugs. 1991. PMID: 1718685 Review.
The systemic absorption of etoposide after intravaginal administration in patients with cervical intraepithelial lesions associated with human papillomavirus infection.
García-López P, Coll M, Cervera E, Reyes-Vermot L, Torres MA, Abrego-Pérez G, Hernández-Pájaro AI, Castañeda-Hernandez G, Mohar-Betancourt A, Meneses A. García-López P, et al. Pharm Res. 2006 Feb;23(2):378-83. doi: 10.1007/s11095-005-9142-3. Epub 2006 Jan 1. Pharm Res. 2006. PMID: 16388409 Clinical Trial.
Pharmacokinetic drug interactions with anticancer drugs.
Loadman PM, Bibby MC. Loadman PM, et al. Clin Pharmacokinet. 1994 Jun;26(6):486-500. doi: 10.2165/00003088-199426060-00006. Clin Pharmacokinet. 1994. PMID: 8070221 Review.
Substituted 4,5'-Bithiazoles as Catalytic Inhibitors of Human DNA Topoisomerase IIα.
Bergant Loboda K, Janežič M, Štampar M, Žegura B, Filipič M, Perdih A. Bergant Loboda K, et al. J Chem Inf Model. 2020 Jul 27;60(7):3662-3678. doi: 10.1021/acs.jcim.0c00202. Epub 2020 Jun 22. J Chem Inf Model. 2020. PMID: 32484690 Free PMC article.
Potential cost savings of oral versus intravenous etoposide in the treatment of small cell lung cancer.
Pashko S, Johnson DH. Pashko S, et al. Pharmacoeconomics. 1992 Apr;1(4):293-7. doi: 10.2165/00019053-199201040-00006. Pharmacoeconomics. 1992. PMID: 10147019

See all "Cited by" articles

References

1. Lancet. 1984 Jun 2;1(8388):1232 - PubMed
1. Blood. 1988 Nov;72(5):1567-73 - PubMed
1. Cancer Treat Rep. 1983 Apr;67(4):397-8 - PubMed
1. Eur J Cancer Clin Oncol. 1986 Feb;22(2):173-9 - PubMed
1. Cancer Chemother Pharmacol. 1982;7(2-3):231-3 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer
Other Literature Sources
- The Lens - Patent Citations Database